Related Experiment Video

Updated: Aug 10, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Role of Bcl-2 and its post-transcriptional modification in response to antitumor therapy

G Pratesi1, P Perego, F Zunino

  • 1Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133, Milan, Italy. pratesi@istitutotumori.mi.it

Biochemical Pharmacology
|February 28, 2001
PubMed

Insights

Bcl-2 protein, a key regulator of apoptosis, functions at the mitochondria. Its phosphorylation is a crucial mechanism influencing its anti-apoptotic role, particularly in cancer chemotherapy.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The Bcl-2 protein is a critical regulator of apoptosis, primarily functioning at the mitochondrial membrane.
  • Mitochondria integrate pro- and antiapoptotic signals, playing a central role in programmed cell death.
  • Dysregulation of Bcl-2 expression is common in human tumors, making it a target for cancer chemotherapy.

Purpose of the Study:

  • To explore the regulatory role of Bcl-2 phosphorylation in apoptosis.
  • To investigate the involvement of various signaling pathways in Bcl-2 phosphorylation in response to cellular stress.
  • To provide insights for designing novel anti-cancer therapeutic strategies.

Main Methods:

  • Review of current literature on Bcl-2 function, phosphorylation, and its role in apoptosis.
  • Analysis of signaling pathways implicated in Bcl-2 phosphorylation by different stress stimuli.
  • Examination of the link between Bcl-2 phosphorylation and drug-induced cell death.

Main Results:

  • Bcl-2 phosphorylation is a significant regulatory mechanism of its antiapoptotic function.
  • Phosphorylation is a common response to antimitotic drugs and observed with DNA-damaging agents in some tumor systems.
  • Diverse signaling pathways, dependent on activated kinases, mediate Bcl-2 phosphorylation in response to various stress stimuli.

Conclusions:

  • Understanding Bcl-2 phosphorylation mechanisms is key to modulating its function.
  • Targeting Bcl-2 phosphorylation offers potential for enhancing cancer chemotherapy efficacy.
  • Further research into these molecular mechanisms can guide rational drug design for cancer treatment.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.